Novartis Ag (NVS) Other Non Operating Income (2009 - 2026)

Novartis Ag has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$17.0 million for Q2 2026.

• In Q2 2026, Other Non Operating Income rose 58.54% year-over-year to -$17.0 million; the TTM figure through Jun 2026 stood at -$179.0 million (down 264.22% YoY), while the FY2025 annual figure was -$136.0 million, down 197.14% from the prior year.
• Other Non Operating Income came in at -$17.0 million for Q2 2026 at Novartis Ag, up from -$50.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $204.0 million in Q4 2023 to a low of -$92.0 million in Q4 2025.
• Average Other Non Operating Income over 5 years is $25.7 million, with a median of $16.5 million recorded in 2022.
• Year-over-year, Other Non Operating Income soared 466.67% in 2023 and sank 394.12% in 2026.
• Over 5 years, Other Non Operating Income stood at $36.0 million in 2022, then soared by 466.67% to $204.0 million in 2023, then plunged by 47.55% to $107.0 million in 2024, then slumped by 185.98% to -$92.0 million in 2025, then surged by 81.52% to -$17.0 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$17.0 million in Q2 2026, -$50.0 million in Q1 2026, and -$92.0 million in Q4 2025.